BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang J, Huang H, Xiao D, Duan Y, Zheng Y, Chen Z. Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells. Int J Oncol 2021;58:15. [PMID: 33760171 DOI: 10.3892/ijo.2021.5195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Xie A, Xu X, Kuang P, Zhang L, Yu F. TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR. Cell Death Dis 2021;12:804. [PMID: 34429402 DOI: 10.1038/s41419-021-04086-9] [Reference Citation Analysis]
2 Wang Z, Xiong H, Zuo Y, Hu S, Zhu C, Min A. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway. Cell Cycle 2022;:1-12. [PMID: 34979867 DOI: 10.1080/15384101.2021.2021722] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Spano D, Colanzi A. Golgi Complex: A Signaling Hub in Cancer. Cells 2022;11:1990. [DOI: 10.3390/cells11131990] [Reference Citation Analysis]
4 Xu W, Li Y, Ye X, Ji Y, Chen Y, Zhang X, Li Z. TMED3/RPS15A Axis promotes the development and progression of osteosarcoma. Cancer Cell Int 2021;21:630. [PMID: 34838013 DOI: 10.1186/s12935-021-02340-w] [Reference Citation Analysis]
5 Zhang D, Sun L, Zhang J. TMED3 exerts a protumor function in non-small cell lung cancer by enhancing the Wnt/β-catenin pathway via regulation of AKT. Toxicol Appl Pharmacol 2021;433:115793. [PMID: 34758370 DOI: 10.1016/j.taap.2021.115793] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]